Phase 2b Study Evaluating the Safety and Efficacy of AP01 in Participants With PPF

Conditions: Progressive Pulmonary Fibrosis Interventions: Drug: AP01; Other: Placebo Sponsors: Avalyn Pharma Inc.; DevPro Biopharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials